Background: Central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) is a devastating complication; the optimal prophylactic strategy remains unclear
Objective: Relapses of Central Nervous System of Diffuse Large B-Cell Lymphoma are not common and th...
Background: Incidence of central nervous system (CNS) recurrence in patients with aggressive non-Hod...
De novo diffuse large B-cell lymphoma (DLBCL) presenting with synchronous central nervous system (CN...
BACKGROUND: Central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) is a devas...
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.Central nervous system (CNS) involv...
Abstract Background In patients with diffuse large B-cell lymphoma (DLBCL), central nervous system (...
Abstract Although overall survival in diffuse large B cell lymphomas (DLBCL) has improved, central ...
Diffuse large B-cell lymphoma patients have a 5% overall risk of central nervous system events (rela...
Central nervous system (CNS) relapse of diffuse large B-cell lymphoma remains uncommon but catastrop...
Diffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell lymphoma curable even in advanced stag...
Abstract Although methotrexate (MTX) is the most widely used therapy for central nervous system (CNS...
International audienceMost patients with diffuse large B-cell lymphoma (DLBCL) can be cured with imm...
We performed a national population-based study of all patients diagnosed with diffuse large B-cell l...
Secondary central nervous system (CNS) involvement in diffuse large B-cell lymphoma (DLBCL) includes...
Survival of patients with high-risk diffuse large B-cell lymphoma (DLBCL) is suboptimal, and the ris...
Objective: Relapses of Central Nervous System of Diffuse Large B-Cell Lymphoma are not common and th...
Background: Incidence of central nervous system (CNS) recurrence in patients with aggressive non-Hod...
De novo diffuse large B-cell lymphoma (DLBCL) presenting with synchronous central nervous system (CN...
BACKGROUND: Central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) is a devas...
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.Central nervous system (CNS) involv...
Abstract Background In patients with diffuse large B-cell lymphoma (DLBCL), central nervous system (...
Abstract Although overall survival in diffuse large B cell lymphomas (DLBCL) has improved, central ...
Diffuse large B-cell lymphoma patients have a 5% overall risk of central nervous system events (rela...
Central nervous system (CNS) relapse of diffuse large B-cell lymphoma remains uncommon but catastrop...
Diffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell lymphoma curable even in advanced stag...
Abstract Although methotrexate (MTX) is the most widely used therapy for central nervous system (CNS...
International audienceMost patients with diffuse large B-cell lymphoma (DLBCL) can be cured with imm...
We performed a national population-based study of all patients diagnosed with diffuse large B-cell l...
Secondary central nervous system (CNS) involvement in diffuse large B-cell lymphoma (DLBCL) includes...
Survival of patients with high-risk diffuse large B-cell lymphoma (DLBCL) is suboptimal, and the ris...
Objective: Relapses of Central Nervous System of Diffuse Large B-Cell Lymphoma are not common and th...
Background: Incidence of central nervous system (CNS) recurrence in patients with aggressive non-Hod...
De novo diffuse large B-cell lymphoma (DLBCL) presenting with synchronous central nervous system (CN...